logo
  

Vertex Pharmaceuticals Lifts FY21 Revenue Outlook

Vertex Pharmaceuticals Inc. (VRTX) lifts its full year 2021 revenue outlook. The company now expects revenues of $7.2 billion to $7.4 billion for the full year 2021.

Analysts polled by Thomson Reuters currently expect revenues of $6.99 billion for the year. Previously, the company expected revenues of $6.7 billion to $6.9 billion.

Meanwhile, the company maintained its outlook for combined R&D and SG&A expenses for the full year of $3.8 billion to $3.95 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Green Field Farms Dairy has recalled its Whole Chocolate Milk product as a laboratory analysis indicated that the product was not effectively pasteurized, the U.S. Food and Drug Administration announced. The recall involves 1,242 units of the Whole Chocolate Milk with an expiration date of September 29, 2021. General Motors will start replacing defective battery modules in Chevrolet Bolt EVs and EUVs with new modules. The replacement battery modules will be shipped to dealers as soon as mid-October, the automaker said in a statement. CVS Health is set to recruit qualified candidates to fill 25,000 clinical and retail jobs during a one-day national career event on Friday, September 24. This will enable CVS to meet the high demand for pharmacists, pharmacy technicians, nurses, and retail store associates to support flu season, COVID-19 vaccinations and testing.
Follow RTT